BioSpace News Archive

BTD is an FDA program designed to expedite the development and review of therapeutic candidates intended to treat serious or life-threatening diseases.

Add-on Payment Increased from 50 to 65 Percent; Supports Patient Access by Providing Additional Medicare Reimbursement in the Hospital Setting

Mr. Sender brings over 30 years of financial leadership experience, with a strong track record of success.

Mr. Fleet has also been elected to serve as a member of the Company’s Board of Directors.

A global data analytics and advisory firm, Quantzig, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of their latest customer segmentation analytics engagement for a pharmaceutical company.

Presentations on bio-layer interferometry for improved formulation screening and use of new excipients to prevent particle formation

BTG plc (LSE: BTG), the global healthcare company, today announced the start of a randomized double-blinded clinical study, initiated by researchers at the University of Maryland School of Medicine (UMSOM), that examines the role of DigiFab® (Digoxin Immune FAB (ovine)) in patients with an elevated risk of acute kidney injury undergoing coronary artery bypass graft (CABG) surgery.

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center (“MD Anderson”), today announced that the company has identified the fourth and final site as well as the supervising physician for its upcoming expanded pivotal Cellulite Trial.

Innoplexus, a leader in artificial intelligence (AI) solutions for the life sciences industry, has partnered with the nonprofit Cures Within Reach for Cancer to pave the way for faster and more effective identification of new, affordable cancer treatments among existing non-cancer generic and off-patent drugs.

TTP Labtech Ltd, a global leader in the design and development of automated instrumentation and consumables for life science applications, has today announced the introduction of chameleon, an industry-enabling sample-preparation system for cryo-electron microscopy (cryo-EM).